Lancaster General Health Neuroscience Institute — Lancaster, Pennsylvania

Lancaster General Health Neuroscience Institute is a clinical research site located in Lancaster, Pennsylvania, United States 17601.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Lancaster General Health Neuroscience Institute has participated in 1 clinical trials.

Therapeutic areas: Prevention of Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, High-risk Transient Ischemic Attack.

Sponsors: Bayer.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lancaster General Health Neuroscience Institute?

Lancaster General Health Neuroscience Institute has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lancaster General Health Neuroscience Institute conducted?

Lancaster General Health Neuroscience Institute has 1 clinical trials on record. Their work covers Prevention of Ischemic Stroke, Acute Non-cardioembolic Ischemic Stroke, High-risk Transient Ischemic Attack.

Is Lancaster General Health Neuroscience Institute accredited by Crixeo Health?

Lancaster General Health Neuroscience Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lancaster General Health Neuroscience Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.